表紙
市場調査レポート

血栓症:世界の治験レビュー

Thrombosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 232261
出版日 ページ情報 英文 154 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
血栓症:世界の治験レビュー Thrombosis Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 154 Pages
概要

血栓症とは、血の塊(血栓)が血管内に形成され、循環系における血流が妨げられる状態をいいます。血管が傷つくと、まず人体では止血のために血小板とフィブリンで凝血塊を形成されます。しかしこの凝固が過度であると、凝血塊が遊離し、血管内で血栓が形成されます。

当レポートでは、血栓症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどを提供しています。

イントロダクション

  • 血栓症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:心血管疾患治療薬の治験における血栓症治療薬の比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:心血管疾患治療薬の治験における血栓症治療薬の比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

血栓症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • C. H. Boehringer Sohn AG & Co. KG
    • Bayer AG
    • Sanofi
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • AstraZeneca PLC
    • Bristol-Myers Squibb Company
    • 第一三共
    • アステラス製薬
    • The LEO Foundation
  • 代表的な研究機関・病院の治験の概要
    • National Heart, Lung, and Blood Institutete
    • Hamilton Health Sciences
    • Brigham and Women's Hospital
    • Ottawa Hospital Research Institute
    • Assistance Publique - Hopitaux de Paris
    • McMaster University
    • Seoul National University Hospital
    • Academic Medical Center
    • Medical University of Vienna
    • Beijing Chao-Yang Hospital

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Thrombosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Thrombosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Thrombosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • The LEO Foundation
      • Clinical Trial Overview of The LEO Foundation
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • McMaster University
      • Clinical Trial Overview of McMaster University
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Beijing Chao-Yang Hospital
      • Clinical Trial Overview of Beijing Chao-Yang Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Thrombosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Thrombosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao-Yang Hospital, 2014*

List of Figures

  • Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top